Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 2913 - 2920 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC7478 | Philanthotoxin 74 |
|
AMPA receptor antagonist. Non-selective homomeric GluA3 and GluA1 receptor antagonist (IC50 values are 263 and 296 nM respectively). Inhibits homomeric GluA3 and GluA1 with a 100-fold greater potency than heteromeric GluA1/2 and GluA2/3 receptors.
|
|
| BCC7479 | Nefazodone hydrochloride |
|
Serotonin 5-HT2A receptor antagonist (Ki = 5.8 nM) and inhibitor of serotonin and noradrenalin uptake (IC50 values are 290 and 300 nM respectively). Displays no activity at 5-HT1B and 5-HT1D receptors. Active in models predictive of antidepressant potential.
|
|
| BCC7480 | Antalarmin hydrochloride |
|
Non-peptide corticotropin-releasing hormone receptor 1 (CRF1) antagonist (Ki = 1 nM). Suppresses CRF-induced ACTH secretion. Blocks CRF- and novelty-induced anxiety-like behavior in animal models of anxiety.
|
|
| BCC7481 | CP 154526 |
|
Selective, non-peptide CRF1 receptor antagonist (Ki values are 2.7 and > 10000 nM for CRF1 and CRF2 receptors respectively). Blocks CRF-induced adenylate cyclase activation (Ki = 3.7 nM) and attenuates activation of the HPA axis by CRF. Displays anxiolytic-like activity in the rat elevated plus-maze test; brain penetrant.
|
|
| BCC7482 | TCS 46b |
|
Orally active, subtype-selective GluN1A/GluN2B (formally NR1A/NR2B) NMDA receptor antagonist (IC50 values are 5.3, 35000 and > 100000 nM for GluN1A/2B (NR1A/2B), GluN1A/2B (NR1A/2B) and GluN1A/2C (NR1A/2C) receptor subtypes respectively). Potentiates the effect of L-DOPA in 6-OHDA-lesioned rats following oral administration.
|
|
| BCC7483 | BAPTA |
|
Selective calcium chelator.
|
|
| BCC7484 | NFPS |
|
Selective, non-transportable inhibitor of GlyT1 which displays no activity at GABA or glutamate receptors (IC50 values are 2.8, 9.8 and 56000 nM for hGlyT1, rGlyT1 and rGlyT2 respectively). Enhances the amplitude of the NMDA component of glutamatergic EPSCs.
|
|
| BCC7485 | Jasplakinolide |
|
Rapidly stabilizes pre-formed actin filaments and inhibits their disassembly <em>in vitro</em>. Also induces polymerization of actin monomers into F-actin <em>in vivo</em>. Shown to bind to F-actin competitively with phalloidin (K<sub>d</sub> ~ 15 nM). Exhibits antifungal and antiproliferative effects (IC<sub>50</sub> = 35 nM for antiproliferative activity in PC3 cells). Cell permeable.
|
|